| Multivariate Analysis | ||
---|---|---|---|
HR | 95% CI | p | |
Overall neutrophil nadir (n = 196) | |||
 Overall survival | 1.36 | 1.12–1.66 | <0.01 |
 Distant control | 1.32 | 1.01–1.73 | 0.05 |
Pre treatment neutrophil count (n = 194) | |||
 Overall survival | 1.28 | 1.02–1.61 | 0.03 |
 Cancer-specific survival | 1.32 | 1.10–1.59 | <0.01 |
 Distant control | 1.48 | 1.13–1.95 | <0.01 |
Post treatment neutrophil count (n = 136) | |||
 Overall survival | 1.35 | 1.04–1.74 | 0.02 |
 Local control | 1.58 | 1.21–2.07 | <0.01 |
Overall NLR | |||
 Distant control | 1.06 | 1.01–1.11 | 0.02 |
Pre treatment NLR | |||
 Overall survival | 1.09 | 1.01–1.17 | 0.03 |